Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Novavax, Inc. , a global company advancing protein-based vaccines with its novel Matrix-Mtm adjuvant, today announced that the Company granted a non- qualified stock option and restricted stock units ...

Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

China: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors ...

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney ...

Medicare is lauded as one of the most robust in the world - yet ask any woman with chronic pain how they would rate their ...

During the 1990s, Ethicon's Endo-Surgery pioneered minimally invasive ... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data.

Automotive Grade Linux has announced the launch of a new open source program office Expert Group for Software-Defined ...